Most Read Articles
01 Jan 2015
Ginkgo biloba has been shown to improve cognitive as well as neuropsychiatric symptoms (NPS) in patients with Alzheimer’s disease (AD) and mixed dementia. During a Schwabe-sponsored symposium last 20 October 2014 held at the University of Malaya in Malaysia, Professor Serge Gauthier of the McGill Centre for Studies in Aging in Quebec, Canada, and Dr Robert Hoerr of the Dr Willmar Schwabe GmbH & Co. KG in Germany, discussed studies that support the safety and efficacy of Ginkgo biloba extract (EGb 761®) in patients with AD and dementia.
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.

Injuries, hospital transfers up risk of 14-day rehospitalization after tSCI

04 Sep 2017

Delayed traumatic spinal cord injury (tSCI) diagnoses, interhospital transfers and injuries in the chest, brain and abdominal area are risk factors for 14-day rehospitalization with new tSCI, a recent study has shown.

Of the 23,617 patients with initial tSCI, 997 were rehospitalized within 14 days for new tSCI, yielding an incidence rate of 4.22 percent. The remaining 22,620 were designated as the control group. Matching at a 1:4 ratio resulted in a total of 4,985 patients, 997 of which were cases while 3,988 were controls.

In the multiple logistic regression analysis, interhospital transfer (odds ratio [OR], 8.20; 95 percent CI, 6.48 to 10.38; p<0.0001) significantly increased the risk of 14-day rehospitalization. In contrast, high disease severities (OR for injury severity score [ISS] 16 to 24, 0.17; 0.13 to 0.21; p<0.0001; OR for ISS >24 OR, 0.11; 0.07 to 0.18; p<0.0001) were associated with significantly lower risks of rehospitalization.

Associated injuries in the brain (OR, 2.82 2.36 to 3.37; p<0.0001), chest (OR, 2.99; 2.14 to 4.19; p<0.0001) and abdomen (OR, 2.74; 1.62 to 4.62; p=0.0002) also significantly increased the risk of 14-day rehospitalization.

Similarly, injuries in the thoracic (OR, 1.62; 1.21 to 2.18; p=0.0012), lumbar (OR, 1.30; 1.02 to 1.65; p=0.0352) and multiple (OR, 3.23; 1.86 to 5.61; p<0.0001) levels also raised the 14-day rehospitalization risk compared with injuries at the cervical level.

Other risk factors included hospitalization in the orthopaedic department (OR, 2.26; 1.78 to 2.87; p<0.0001), motor vehicle collision injuries (OR, 1.36; 1.12 to 1.65; p=0.0019) and pelvic injuries (OR, 1.84; 1.02 to 3.32; p=0.0427).

Editor's Recommendations
Most Read Articles
01 Jan 2015
Ginkgo biloba has been shown to improve cognitive as well as neuropsychiatric symptoms (NPS) in patients with Alzheimer’s disease (AD) and mixed dementia. During a Schwabe-sponsored symposium last 20 October 2014 held at the University of Malaya in Malaysia, Professor Serge Gauthier of the McGill Centre for Studies in Aging in Quebec, Canada, and Dr Robert Hoerr of the Dr Willmar Schwabe GmbH & Co. KG in Germany, discussed studies that support the safety and efficacy of Ginkgo biloba extract (EGb 761®) in patients with AD and dementia.
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.